Disease Synopsis
Overview
Drugs and Clinical Candidates
Clinical Trials (visual)
Clinical Trials (text)
Cell Line Models
Chemistry

Male Cancers - Overview - Disease Synopsis

Drugs & Clinical Candidates


7 drugs have received FDA approval for Male Cancers . Bleomycin Sulfate, Cisplatin, Dactinomycin, Etoposide, Etoposide Phosphate, Ifosfamide and Vinblastine Sulfate
113 drugs have a clinical trial registered for Male Cancers.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Clinical Trials


There are 290 clinical trials for Male Cancers,
193 of which have one or more drug interventions,
97 with no drug intervention.

Sources: cancer.gov and clinicaltrials.gov
(see details)

Cell Line Models


There are 39 Cell Line Models for Male Cancers.

Source: COSMIC
(see details)

Chemistry


There are 1195 Compounds which have been tested in Male Cancers , 904 <= 500nM potency.

Source: ChEMBL
(see details)

Mappings


Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Male Cancers:
Breast Neoplasms, Male
Genital Neoplasms, Male
Leydig Cell Tumor
Penile Neoplasms
Sertoli-Leydig Cell Tumor
Testicular Neoplasms

The following terms have been mapped from cancer.gov to Male Cancers:
Penile cancer
Testicular cancer
Testicular cancer that has metastasized in patients who have already had surgery or radiation therapy
Testicular cancer. It is used in patients who have already been treated with surgery, radiation therapy, or other chemotherapy and have not gotten better
Testicular cancer. It is used for nonseminomas that have metastasized (spread to other parts of the body)
Testicular cancer. It is used in patients who have already been treated with surgery, radiation therapy, or other chemotherapy and have not gotten better
Testicular germ cell tumors that are malignant. It is used in patients who have already been treated with two other types of chemotherapy